Tapestry, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:Tapestry, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C11357
◆発行会社(調査会社):MarketLine
◆発行日:2018年11月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:小売り
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥23,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥47,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥70,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Tapestry, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Tapestry, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Tapestry, Inc. (Tapestry or ‘the company’) formerly Coach, Inc., is a designer and marketer of modern luxury accessories and lifestyle brands for men and women. The company’s product portfolio includes bags, small leather goods, footwear, jewelry, business cases, eye-wear, travel bags, watches and other lifestyle products. It operated through a multi-channel wide network including retail outlets, directly operated concession shop-in-shops, department and specialty stores and e-commerce channels. The company operates in North America, Europe, and Asia. Tapestry is headquartered in New York City, New York, the US.

Scope

- Detailed information on Tapestry, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Tapestry, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Tapestry, Inc. including a breakdown and examination of key business segments
- Intelligence on Tapestry, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Tapestry, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Tapestry, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Tapestry, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Tapestry, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Tapestry, Inc.: Company Overview 9
Tapestry, Inc.: Overview and Key Facts 9
Tapestry, Inc.: Overview 9
Tapestry, Inc.: Key Facts 9
Tapestry, Inc.: Key Employees 10
Tapestry, Inc.: Key Employee Biographies 11
Tapestry, Inc.: Major Products and Services 14
Tapestry, Inc.: Company History 15
Tapestry, Inc.: Management Statement 20
Tapestry, Inc.: Key Competitors 24
Tapestry, Inc.: Company Analysis 25
Tapestry, Inc.: Business Description 25
Tapestry, Inc.: SWOT Analysis 27
Tapestry, Inc.: SWOT Overview 27
Tapestry, Inc.: Strengths 27
Tapestry, Inc.: Weaknesses 28
Tapestry, Inc.: Opportunities 29
Tapestry, Inc.: Threats 29
Tapestry, Inc.: Corporate Financial Deals Activity 31
Tapestry, Inc.: Financial Deals Overview 31
Tapestry, Inc.: Targets and Partners 32
Tapestry, Inc.: Top Deals 2014 – 2018YTD* 33
Tapestry, Inc.: Advisors 34
Tapestry, Inc.: Top Legal Advisors 34
Tapestry, Inc.: Top Financial Advisors 34
Tapestry, Inc.: Mergers and Acquisitions 35
Tapestry, Inc.: Capital Raising 36
Tapestry, Inc.: Partnership 37
Tapestry, Inc.: Recent Developments 38
Tapestry, Inc.: News and Events Summary 38
Tapestry, Inc.: Business Expansion 41
Tapestry, Inc.: Contracts 42
Tapestry, Inc.: Corporate Governance 43
Tapestry, Inc.: Financial Performance 44
Tapestry, Inc.: Strategy and Operations 44
Appendix 46
Contact Us 46
Methodology 46
About MarketLine 47

List of Tables
Table 1: Tapestry, Inc.: Key Facts
Table 2: Tapestry, Inc.: Key Employees
Table 3: Tapestry, Inc.: Company History
Table 4: Tapestry, Inc.: Key Competitors
Table 5: Tapestry, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: Tapestry, Inc.: M&A Average Deal Size - Value (US$m)
Table 7: Tapestry, Inc.: Targets and Partners
Table 8: Tapestry, Inc.: Top Deals 2014 - 2018YTD*
Table 9: Tapestry, Inc.: Legal Advisor Ranking by Value (US$m)
Table 10: Tapestry, Inc.: Financial Advisor Ranking by Value (US$m)
Table 11: Tapestry, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: Tapestry, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 13: Tapestry, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 14: Tapestry, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 15: Tapestry, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 16: Tapestry, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 17: Tapestry, Inc.: News and Events Summary
Table 18: Tapestry, Inc.: Business Expansion
Table 19: Tapestry, Inc.: Contracts
Table 20: Tapestry, Inc.: Corporate Governance
Table 21: Tapestry, Inc.: Financial Performance
Table 22: Tapestry, Inc.: Strategy and Operations

List of Figures
Figure 1: Tapestry, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Tapestry, Inc.: M&A Average Deal Size - Value (US$m)
Figure 3: Tapestry, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: Tapestry, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Figure 5: Tapestry, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 6: Tapestry, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 7: Tapestry, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 8: Tapestry, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Tapestry, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mankind Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Mankind Pharma Ltd (MPL) is a manufacturer and supplier of prescriptions medicines, over-the-counter and FMCG products. The company offers prescription medicines in dosage forms of oral solids, oral liquids, soft gelatine capsules and injectables. Its products are used in therapeutic areas o …
  • Egdon Resources Plc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Egdon Resources Plc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Egdon Resources Plc (Egdon) is oil and gas company that offers exploration and production services. The company explores and develops petroleum and natural gas assets in East Midlands, North East Eng …
  • Sartorius AG (SRT):企業の財務・戦略的SWOT分析
    Sartorius AG (SRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Second Sight Medical Products Inc (EYES):医療機器:M&Aディール及び事業提携情報
    Summary Second Sight Medical Products Inc (Second Sight) is a medical device company that develops, manufactures and markets implantable visual prosthetics for blind individuals. The company offers Argus II retinal prosthesis system, a device that restores some functional vision for people suffering …
  • Olam International Ltd:戦略・SWOT・企業財務分析
    Olam International Ltd - Strategy, SWOT and Corporate Finance Report Summary Olam International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Xped Limited (XPE)-エネルギー分野:企業M&A・提携分析
    Summary Xped Limited (Xped) formerly Raya Group Limited, is an Internet of Things company that develops software and hardware solutions. It offers auto discovery remote control, Xerts, and Xped app software; and hardware such as Xped ADRC Shields, Umbo-Xped ADRC Hub, UltraPlug, VariPlug, IRBlaster. …
  • Suzuken Co Ltd (9987):企業の財務・戦略的SWOT分析
    Suzuken Co Ltd (9987) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Inner Mongolia Yili Industrial Group Co Ltd
    Inner Mongolia Yili Industrial Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Inner Mongolia Yili Industrial Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • GETECH Group plc (GTC):企業の財務・戦略的SWOT分析
    Summary Getech Group Plc (Getech) is an oil and gas service company that offers geological and geophysical services. The company’s services include regional reports, globe, commissions and global gravity and magnetic data solutions. Its in-house specialties comprise airborne geophysics, potential fi …
  • Nick Scali Ltd (NCK):企業の財務・戦略的SWOT分析
    Nick Scali Ltd (NCK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Nerviano Medical Sciences Srl:製薬・医療:M&Aディール及び事業提携情報
    Summary Nerviano Medical Sciences Srl (NMS) is a drug development company that discovers and develops novel anticancer drugs. The company's pipeline products include anticancer compounds such as Danusertib, Encorafenib, Entrectinib, ADC Payload programs, PARP1 program, NMS-088, Brostallicin, Milcicl …
  • Kalvista Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Kalvista Pharmaceuticals Ltd (Kalvista Pharma), formerly Kalvista Limited, is a pharmaceutical company which focuses on the discovery, development and commercialization of small molecule serine protease inhibitors. It develops a proprietary portfolio of small molecule plasma kallikrein inhib …
  • The Binding Site Group Ltd:企業の製品パイプライン分析2018
    Summary The Binding Site Group Ltd (Binding Site) is a clinical diagnostic tools supplier that concentrates on research, development, manufacturing and distribution of immunodiagnostic assays. The company provides product portfolio such as antibodies, antigens, bulk antisera, assays for plasma prote …
  • Vitae Pharmaceuticals Inc (VTAE)-製薬・医療分野:企業M&A・提携分析
    Summary Vitae Pharmaceuticals Inc (Vitae Pharmaceuticals) is a biopharmaceutical company that offers pharmaceutical products. The company discovers and develops and small molecule drugs for diseases with significant unmet medical needs. Its products pipeline includes VTP-34072, BI 1147560, VTP-43742 …
  • Allena Pharmaceuticals Inc (ALNA):製薬・医療:M&Aディール及び事業提携情報
    Summary Allena Pharmaceuticals Inc (Allena) is a developer of oral enzyme therapeutics to treat patients with rare and severe metabolic disorders. The company develops ALLN-177, an oral recombinant oxalate degrading enzyme. It provides ALLN-177 which is developed for the chronic management of hypero …
  • Fieldwood Energy LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Fieldwood Energy LLC (Fieldwood Energy) is an energy and power-focused investment firm. The company operates 500 offshore blocks on the Gulf of Mexico Shelf which focuses on acquiring and developing conventional assets. Fieldwood Energy is portfolio company of Riverstone Holdings LLC. The Co …
  • Sun BioPharma Inc (SNBP):製薬・医療:M&Aディール及び事業提携情報
    Summary Sun BioPharma Inc (Sun BioPharma), formerly Cimarron Medical Inc is a biopharmaceutical company that develops disruptive therapeutics for treatment of pancreatic cancer and pancreatitis. The company’s pipeline products include SBP-101, SBP-102 and SBP-103. Its SBP-101 produces superior anti- …
  • Genting Malaysia Berhad:戦略・SWOT・企業財務分析
    Genting Malaysia Berhad - Strategy, SWOT and Corporate Finance Report Summary Genting Malaysia Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Luitpold Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Luitpold Pharmaceuticals Inc (Luitpold Pharmaceuticals), a subsidiary of Daiichi Sankyo Co Ltd is a manufacturer and marketer of drugs and medical devices. The company provides products such as injectable parenteral medications that are used in pharmacy admixtures and nutrient solutions, cri …
  • Iovance Biotherapeutics Inc (IOVA):企業の財務・戦略的SWOT分析
    Iovance Biotherapeutics Inc (IOVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆